STERIS plc Business Acquisition, Pro Forma Net Income (Loss)
STERIS plc (STE) reported Business Acquisition, Pro Forma Net Income (Loss) of $449.38 million for the 12-month period ending 2022-03-31, per its 10-K filed 2023-05-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2023-05-26
- STERIS plc business acquisition, pro forma net income (loss) for the quarter ending 2022-03-31 was $66.19M.
- STERIS plc business acquisition, pro forma net income (loss) for the quarter ending 2021-12-31 was $152.18M, a 63.80% increase year-over-year.
- STERIS plc business acquisition, pro forma net income (loss) for the quarter ending 2021-09-30 was $137.38M, a 134.46% increase year-over-year.
- STERIS plc business acquisition, pro forma net income (loss) for the quarter ending 2021-06-30 was $93.64M.
- STERIS plc business acquisition, pro forma net income (loss) for fiscal 2022 was $449.38M, a 7583.06% increase from fiscal 2021.
- STERIS plc business acquisition, pro forma net income (loss) for fiscal 2021 was $5.85M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-03-31 | $66.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $218.37M derived: sum of 2 quarters · filed 2023-05-26 | $355.74M derived: sum of 3 quarters · filed 2023-05-26 | $449.38M 10-K · filed 2023-05-26 |
| 2021-12-31 | $152.18M 10-Q · filed 2022-02-09 | $289.55M derived: sum of 2 quarters · filed 2022-02-09 | $383.19M 10-Q · filed 2022-02-09 | $358.24M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-09-30 | $137.38M 10-Q · filed 2021-11-08 | $231.02M 10-Q · filed 2021-11-08 | $206.06M derived: sum of 3 quarters · filed 2023-05-26 | $298.96M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-06-30 | $93.64M 10-Q · filed 2021-08-09 | $68.69M derived: sum of 2 quarters · filed 2023-05-26 | $161.59M derived: sum of 3 quarters · filed 2023-05-26 | $220.18M derived: sum of 4 quarters · filed 2023-05-26 |
| 2021-03-31 | -$24.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $67.95M derived: sum of 2 quarters · filed 2023-05-26 | $126.55M derived: sum of 3 quarters · filed 2023-05-26 | $5.85M 10-K · filed 2023-05-26 |
| 2020-12-31 | $92.90M 10-Q · filed 2022-02-09 | $151.50M derived: sum of 2 quarters · filed 2022-02-09 | $30.80M 10-Q · filed 2022-02-09 | |
| 2020-09-30 | $58.59M 10-Q · filed 2021-11-08 | -$62.11M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$90.38M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |